Search results
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 11 hours agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 day agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 1 day agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 day agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 2 days agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 8 hours agoLoading... Loading... Throughout the last three months, 12 analysts have evaluated BioNTech BNTX , offering a diverse set of opinions from bullish to bearish. The table below ...
Analyst Report: BioNTech SE
Morningstar Research via Yahoo Finance· 1 day agoBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious ...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 2 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 2 days ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 2 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...